A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants

Inclusion Criteria: * Must have a body mass index between 18 and 33 kg/m2 (inclusive) * Adult female of nonchildbearing potential or male, any race or ethnicity, and in good health as determined by the medical history, physical exam, vital signs, 12-lead electrocardiogram, and clinical laboratory assessments Exclusion Criteria: * Any surgical or medical condition possibly affecting drug absorption, distribution, metabolism, and excretion * Any major surgery within 4 weeks of the first dose administration * History of drug abuse within 2 years of the first dose administration Other protocol-defined inclusion/exclusion criteria apply